Ulcerative colitis and Crohn’s disease, collectively known as inflammatory bowel disease (IBD), are 2 chronic inflammatory diseases of the gastrointestinal tract. Although their cause is uncertain, abnormal activation of the immune system and an altered microbiome may be significant contributors. IBD can occur at any age but usually presents before the age of 30. It can be debilitating, with frequent relapses and it is associated with other types of inflammation and an increased risk of colon cancer.
Until recently, nutritional recommendations for IBD treatment were poorly developed and the main approaches were centred around bowel rest. Based on new research, I apply specific anti-inflammatory and microbiome-focussed eating plans, as an addition to the limited existing medical options, to help better manage this disease. My goal is to help induce remission, maintain remission and to reduce the long-term need for anti-inflammatory medications.
